In recent years, GLP-1 receptor agonists have taken center stage in the health and wellness industry, primarily for their effectiveness in managing type 2 diabetes and supporting weight loss. Drugs like Ozempic and Wegovy have fueled a surge in consumer interest in GLP-1 pathways, not only among patients but also in the broader wellness market.ContinueContinue reading “Emerging Trends in GLP-1: Beyond Weight Loss Toward Gut Health and Functional Nutrition”
Wantun Media 